Myriad Genetics Inc (MYGN)

Cost of Revenue

$63.70M

Quarterly · Period ending: · USD

MYGN logo

MYGN Cost of Revenue

Latest reported$63.70M
MYGN Quarterly Cost of Revenue ($0.00 → $63.70M)
High-resolution chart · PNG

MYGN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
63,700,000
62,800,000
63,000,000
61,900,000
61,300,000
61,700,000
59,700,000
63,500,000
64,400,000
64,600,000
61,600,000
57,600,000
57,800,000
59,200,000
53,900,000
50,400,000
49,700,000
48,000,000
45,800,000
47,800,000
53,700,000
50,300,000
0
44,200,000
36,700,000
50,100,000
49,600,000
49,700,000
50,600,000
48,600,000
52,100,000
49,700,000
45,800,000
44,100,000
44,400,000
43,000,000
42,600,000
44,300,000
44,400,000
40,000,000
40,000,000
40,200,000
40,600,000
36,500,000
38,389,000
36,300,000
37,900,000
34,900,000
30,980,000
26,609,000
26,131,000
25,481,000
22,073,000
20,334,000
19,884,000
17,327,000
16,952,000
17,228,000
16,117,000
14,361,000
12,523,000
11,133,000
12,046,000
11,011,000
11,262,000
10,880,000
11,083,000
11,062,000
11,185,000
11,232,000
11,060,000
9,790,000
9,051,000
8,263,000
7,690,000
7,335,000
7,602,000
7,577,000
7,529,000
8,105,000
8,063,000
7,505,000
6,272,000
5,803,000
5,655,000
5,297,000
5,131,000
4,239,000
3,835,000
3,709,000
3,448,000
2,758,000
3,276,000
3,361,000
2,995,000
2,921,000
3,031,147
2,848,591
2,565,334
2,272,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.